CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The SMR project investigates the use of synthetic polysaccharides, RGTA®, as a neuroprotective treatment for ischemic stroke. It aims to translate promising preclinical results into a viable medical solution for stroke patients, potentially improving recovery outcomes.
Stroke is the 2nd cause of death and major handicaps in industrialized countries.
At present, the only available treatment for ischemic stroke are thrombolysis and thrombectomy.
However, very few patients are eligible, and it is therefore absolutely urgent to find an alternative.RGTA® are synthetic polysaccharides, mimicking endogenous macro-molecules called heparan sulphates, that make up the biological networks in which our cells live and reproduce: the extracellular matrix.We have recently in…
ORGANES TISSUS REGENERATION REPARATION REMPLACEMENT
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
France, Paris
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
